Company: MLTX
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001821586-25-000022
Chunk: 22

Company: MoonLake Immunotherapeutics
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 1
Chunk 22
---
 Total$321,877$5,407$—$327,284Of which classified within cash and cash equivalents59,311 372 — 59,683 Of which classified within short-term marketable debt securities262,566 5,035 — 267,601 The following table presents the changes in fair values of the Company’s short-term marketable debt securities, classified as Level 2 financial assets, and recognized in the “Accumulated other comprehensive income” as of September 30, 2025 and 2024:(in thousands)Beginning balance, January 1, 2025$5,407 Other comprehensive income before reclassifications8,663 Amounts reclassified from accumulated other comprehensive income(13,583)Ending balance, September 30, 2025$487(in thousands)Beginning balance, January 1, 2024$2,721 Other comprehensive income before reclassifications13,001 Amounts reclassified from accumulated other comprehensive income(12,492)Ending balance, September 30, 2024$3,230

17

MOONLAKE IMMUNOTHERAPEUTICSNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS SEPTEMBER 30, 2025(Unaudited)

As of September 30, 2025, the Company’s marketable debt securities maturities are all due within one year.

Note 7 — Prepaid Expenses

(in thousands)September 30, 2025December 31, 2024Non-clinical research and clinical development services$17,576$14,136Supply and manufacturing services6,6947,716Insurances1,0361,113Other prepayments1,408453Total$26,714$23,418

Note 8 — Trade and Other Payables

(in thousands)September 30, 2025December 31, 2024Research and development services$19,576$5,081Supply and manufacturing fees payable4,2423,597Consulting and advisory services66039Legal advisory services15193Other payables653182Total$25,282$8,992

Note 9 — Accrued Expenses and Other Current Liabilities

(in thousands)September 30, 2025December 31, 2024Research and development services and license fees$10,679 $2,022 Supply and manufacturing services4,637 4,474 Bonuses and related